Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer (TNBC)
Brief Summary: This is a 3 arm Phase 3 study to evaluate the safety and efficacy of the addition of veliparib plus carboplatin versus the addition of carboplatin to standard neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy in subjects with early stage TNBC.


Options:
A: Arm Label: Epirubicin and Cyclophosphamid followed by Docetaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Epirubicin, Drug: Cyclophosphamide, Drug: Docetaxel | Arm Label: Combination of Docetaxel and Cyclophosphamid; Type: EXPERIMENTAL; Interventions: Drug: Cyclophosphamide, Drug: Docetaxel | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): Epirubicin and Cyclophosphamid followed by Docetaxel | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Epirubicin and Cyclophosphamid followed by Docetaxel | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Epirubicin and Cyclophosphamid followed by Docetaxel | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Combination of Docetaxel and Cyclophosphamid | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Combination of Docetaxel and Cyclophosphamid
B: Arm Label: Induction Therapy; Type: EXPERIMENTAL; Interventions: Other: Induction therapy | Intervention Type: OTHER; Name: Induction therapy; Assigned to Arm(s): Induction Therapy
C: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Doxorubicin, Drug: Paclitaxel, Drug: Carboplatin, Drug: Veliparib | Arm Label: Arm C; Type: PLACEBO_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Placebo, Drug: Doxorubicin, Drug: Paclitaxel | Arm Label: Arm B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Doxorubicin, Drug: Paclitaxel, Drug: Carboplatin, Drug: Placebo | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Arm A, Arm B, Arm C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm C | Intervention Type: DRUG; Name: Doxorubicin; Assigned to Arm(s): Arm A, Arm B, Arm C | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Arm A, Arm B, Arm C | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Arm A, Arm B | Intervention Type: DRUG; Name: Veliparib; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm B, Arm C
D: Arm Label: Anthracycline - Taxane; Type: ACTIVE_COMPARATOR; Interventions: Drug: Epirubicin, Drug: Cyclophosphamide, Drug: Docetaxel, Drug: Paclitaxel | Arm Label: Taxane - Anthracycline; Type: EXPERIMENTAL; Interventions: Drug: Epirubicin, Drug: Cyclophosphamide, Drug: Docetaxel, Drug: Paclitaxel | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): Anthracycline - Taxane, Taxane - Anthracycline | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Anthracycline - Taxane, Taxane - Anthracycline | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Anthracycline - Taxane, Taxane - Anthracycline | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Anthracycline - Taxane, Taxane - Anthracycline

Answer: C